{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:28:28Z","timestamp":1787610508468,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jpurol.2019.12.013","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T11:29:27Z","timestamp":1577446167000},"page":"181.e1-181.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Intradetrusor onabotulinum-a toxin injections in children with therapy-resistant idiopathic detrusor overactivity. A retrospective study"],"prefix":"10.1016","volume":"16","author":[{"given":"Annelies","family":"Ringoir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Dhondt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"De Bleser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Van Laecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Everaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luitzen Albert","family":"Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Hoebeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Fran\u00e7oise","family":"Spinoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jpurol.2019.12.013_bib1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s11934-014-0426-1","article-title":"Botulinum toxin A's expanding role in the management of pediatric lower urinary tract dysfunction","volume":"15","author":"Hassouna","year":"2014","journal-title":"Curr Urol Rep"},{"issue":"6","key":"10.1016\/j.jpurol.2019.12.013_bib2","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.juro.2010.02.009","article-title":"Outcomes of intravesical botulinum toxin for idiopathic overactive bladder symptoms: a systematic review of the literature","volume":"183","author":"Anger","year":"2010","journal-title":"J Urol"},{"issue":"12","key":"10.1016\/j.jpurol.2019.12.013_bib3","article-title":"Botulinum toxin injections for adults with overactive bladder syndrome","author":"Duthie","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.jpurol.2019.12.013_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.eururo.2013.04.001","article-title":"OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial","volume":"64","author":"Chapple","year":"2013","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.jpurol.2019.12.013_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000351037","article-title":"Botulinum toxin-A injections for idiopathic overactive bladder: a systematic review and meta-analysis","volume":"91","author":"Cui","year":"2013","journal-title":"Urol Int"},{"issue":"3","key":"10.1016\/j.jpurol.2019.12.013_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0090-4295(01)01641-7","article-title":"Efficacy of botulinum-a toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results","volume":"59","author":"Schulte-Baukloh","year":"2002","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.jpurol.2019.12.013_bib7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/nau.22751","article-title":"The standardization of terminology of lower urinary tract function in children and adolescents: update report from the standardization committee of the international Children's continence society","volume":"35","author":"Austin","year":"2016","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"10.1016\/j.jpurol.2019.12.013_bib8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-5347(06)00301-6","article-title":"The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor","volume":"176","author":"Hoebeke","year":"2006","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.jpurol.2019.12.013_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1055\/s-0029-1246193","article-title":"Effectiveness of botulinum-A toxin for the treatment of refractory overactive bladder in children","volume":"20","author":"Marte","year":"2010","journal-title":"Eur J Pediatr Surg"},{"issue":"9","key":"10.1016\/j.jpurol.2019.12.013_bib10","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.jpedsurg.2014.04.004","article-title":"Botulinum toxin injections in the management of non-neurogenic overactive bladders in children","volume":"49","author":"L\u00e9on","year":"2014","journal-title":"J Pediatr Surg"},{"issue":"1","key":"10.1016\/j.jpurol.2019.12.013_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpurol.2018.08.007","article-title":"Onabotulinum toxin A in children with refractory idiopathic overactive bladder: medium term outcomes","volume":"15","author":"Ingham","year":"2019","journal-title":"J Pediatr Urol"},{"issue":"6 Pt A","key":"10.1016\/j.jpurol.2019.12.013_bib12","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jpurol.2012.08.011","article-title":"Intravesical botulinum type-A toxin (Dysport\u00ae) in the treatment of idiopathic detrusor overactivity in children","volume":"9","author":"Blackburn","year":"2013","journal-title":"J Pediatr Urol"},{"issue":"3","key":"10.1016\/j.jpurol.2019.12.013_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00383-011-3039-5","article-title":"Urinary incontinence in children: botulinum toxin is a safe and effective treatment option","volume":"28","author":"McDowell","year":"2012","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.jpurol.2019.12.013_bib14","series-title":"Campbell-Walsh urology","first-page":"3121","article-title":"Development and assessment of lower urinary tract function in children","author":"Yeung","year":"2016"},{"issue":"3 Pt 1","key":"10.1016\/j.jpurol.2019.12.013_bib15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.juro.2007.05.014","article-title":"Overactive bladder in children. Part 1: Pathophysiology","volume":"178","author":"Franco","year":"2007","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.jpurol.2019.12.013_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MOU.0b013e328346d4bb","article-title":"New ideas in the cause of bladder dysfunction in children","volume":"21","author":"Franco","year":"2011","journal-title":"Curr Opin Urol"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513119304371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513119304371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:48:22Z","timestamp":1761486502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513119304371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1477513119304371"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2019.12.013","relation":{},"ISSN":["1477-5131"],"issn-type":[{"value":"1477-5131","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intradetrusor onabotulinum-a toxin injections in children with therapy-resistant idiopathic detrusor overactivity. A retrospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2019.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}